we create mRNA therapies that instruct specific cells on how to make their own medicine
Kernal Biologics is an award-winning startup developing mRNA immunotherapies. Kernal Biologics was founded by four young scientists. Together, we bring a broad range of experience from synthetic biology, immuno-oncology, and deep learning.
Our vision is to develop curative immunotherapies for covid-19 and cancers with high unmet medical need by using deep learning and synthetic biology.
Thanks to our unique methods of codon-engineering and smart design, our proprietary platform decreases immunogenicity upon existing mRNA technologies and enables cell-specific therapeutic protein expression. This allows us to design and develop more efficacious, tolerable, and affordable medicine for the global market.